Ningbo David Financials

300314 Stock   12.62  0.28  2.27%   
You can employ fundamental analysis to find out if Ningbo David Medical is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to analyze twenty-eight available fundamentals for Ningbo David, which can be compared to its peers in the industry. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Ningbo David to be traded at 15.14 in 90 days. Key indicators impacting Ningbo David's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income76.6 M143.2 M
Way Down
Slightly volatile
  
Understanding current and past Ningbo David Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ningbo David's financial statements are interrelated, with each one affecting the others. For example, an increase in Ningbo David's assets may result in an increase in income on the income statement.
Please note, the presentation of Ningbo David's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ningbo David's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ningbo David's management manipulating its earnings.

Ningbo David Stock Summary

Ningbo David competes with GRINM Semiconductor, Eastroc Beverage, Penyao Environmental, Orinko Advanced, and Beijing Yanjing. Ningbo David is entity of China. It is traded as Stock on SHE exchange.
Specialization
Health Care, Health Care Equipment & Services
InstrumentChina Stock View All
ExchangeShenzhen Stock Exchange
ISINCNE100001DD1
Business AddressNoNo 2, Keyuan
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.nbdavid.com
Phone86 574 6598 3055
You should never invest in Ningbo David without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Ningbo Stock, because this is throwing your money away. Analyzing the key information contained in Ningbo David's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Ningbo David Key Financial Ratios

Ningbo David's financial ratios allow both analysts and investors to convert raw data from Ningbo David's financial statements into concise, actionable information that can be used to evaluate the performance of Ningbo David over time and compare it to other companies across industries.

Ningbo David Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets965.1M1.1B1.2B1.3B1.4B878.2M
Other Current Liab33.0M50.1M39.7M4.2M2.7M2.6M
Other Liab3.0M2.8M2.5M3.8M4.4M2.6M
Retained Earnings365.3M490.0M527.0M517.3M613.1M309.9M
Accounts Payable72.9M81.3M83.9M81.4M119.2M125.2M
Cash233.9M224.2M336.7M390.9M571.4M296.3M
Other Assets547.8K692.3K768.7K1.3M1.5M1.4M
Net Receivables18.9M15.1M18.7M17.0M23.8M14.7M
Inventory90.5M104.4M137.4M148.3M159.4M88.0M
Other Current Assets4.6M8.7M9.1M3.6M700.4K665.4K
Total Liab136.3M168.6M165.4M193.6M210.6M126.1M
Intangible Assets28.7M27.6M26.6M47.7M46.6M27.7M
Net Tangible Assets761.1M798.1M923.9M961.9M1.1B876.2M
Total Current Assets677.9M804.5M852.5M922.9M992.4M775.2M
Net Invested Capital828.8M953.5M990.5M1.1B1.2B1.0B
Net Working Capital544.4M638.4M691.2M746.2M795.0M684.7M

Ningbo David Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Ningbo David Medical. It measures of how well Ningbo is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Ningbo David brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Ningbo had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Ningbo David has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201920202021202220232024 (projected)
Dividends Paid17.3M14.4M25.9M43.2M28.8M23.0M
Capital Expenditures9.1M24.2M6.5M49.8M40.4M32.0M
Net Income62.1M136.2M80.2M97.6M147.6M74.8M
Change To Inventory(13.3M)(13.5M)(35.3M)(11.4M)(12.3M)(12.9M)
Investments32.9M(107.5M)93.5M(40.8M)71.8M75.3M
Change In Cash86.5M(32.8M)101.7M54.9M167.6M176.0M
Depreciation21.1M21.5M18.9M25.5M27.3M21.2M
Change To Netincome3.2M(13.2M)(43.5M)(11.3M)(10.1M)(10.6M)
End Period Cash Flow232.1M223.4M335.0M389.9M557.5M307.8M
Free Cash Flow79.5M113.5M44.9M61.8M94.8M73.6M
Other Non Cash Items106.2K3.3M2.9M(16.7M)(5.6M)(5.4M)

Ningbo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ningbo David's current stock value. Our valuation model uses many indicators to compare Ningbo David value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ningbo David competition to find correlations between indicators driving Ningbo David's intrinsic value. More Info.
Ningbo David Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.50  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ningbo David Medical is roughly  2.01 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ningbo David by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ningbo David's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Ningbo David Medical Systematic Risk

Ningbo David's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ningbo David volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Ningbo David Medical correlated with the market. If Beta is less than 0 Ningbo David generally moves in the opposite direction as compared to the market. If Ningbo David Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ningbo David Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ningbo David is generally in the same direction as the market. If Beta > 1 Ningbo David moves generally in the same direction as, but more than the movement of the benchmark.

Ningbo David Medical Total Assets Over Time

Ningbo David December 2, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Ningbo David help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ningbo David Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ningbo David Medical based on widely used predictive technical indicators. In general, we focus on analyzing Ningbo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ningbo David's daily price indicators and compare them against related drivers.

Complementary Tools for Ningbo Stock analysis

When running Ningbo David's price analysis, check to measure Ningbo David's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ningbo David is operating at the current time. Most of Ningbo David's value examination focuses on studying past and present price action to predict the probability of Ningbo David's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ningbo David's price. Additionally, you may evaluate how the addition of Ningbo David to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Commodity Directory
Find actively traded commodities issued by global exchanges